European Archives - Page 59 of 1369 - European Medical Journal

Is Mental Illness Linked to Creativity? - EMJ

People with Mental Illness are Often More Creative

New research reveals surprising strengths linked to mental illness, from creativity to resilience and improved long term wellbeing.

immunotherapy

New Dual-Target T Cell Design Boosts Attack on Solid Tumours

Researchers have developed a new strategy that allows engineered T cells to recognize and respond to a single tumour antigen through two coordinated mechanisms.

New Imaging Combo Enhances Salivary Gland Tumour Detection

MRI and Doppler Ultrasound Improve Detection of Salivary Gland Tumours

A prospective study finds that using both diffusion-weighted MRI and spectral Doppler ultrasound significantly improves classification of benign and malignant salivary gland tumours.

New Guidance Sets Standard for Pediatric Antibiotic Allergy Testing - EMJ

New Guidance Sets Standard for Paediatric Antibiotic Allergy Testing

A new US Drug Allergy Registry report outlines standardised paediatric antibiotic allergy testing protocols to curb unnecessary labels and harmonise research.

FAM72

FAM72 Overexpression Linked to Aggressive Hepatocellular Carcinoma

Bioinformatics work identifies FAM72A–D as powerful prognostic markers in liver cancer and unveils a compact FAM72 risk score that outperforms existing gene models.

STI

New Advances Transform HIV and STI Prevention

New review highlights major advances in HIV and STI prevention, diagnostics, and integrated service delivery, urging a unified approach to meet 2030 global goals.

Osteoporosis

Low-Frequency Stimulation Shows Promise for Osteoporosis Prevention

Learn how a pilot trial shows low-frequency electrical stimulation with exercise enhances local bone outcomes in premenopausal women.

How the Brain Changes Across Five Life Stages

Discover how the brain’s structural networks evolve in five distinct phases across the human lifespan, from childhood to late ageing.

Dupilumab Improves Quality of Life in Chronic Urticaria

A phase 3 trial shows dupilumab significantly improves quality of life in omalizumab-naïve patients with chronic spontaneous urticaria.

Dual Approach Shows Promise in Advanced KRAS G12C-Mutated Lung Cancer

Dual Approach Shows Promise in Advanced KRAS G12C-Mutated Lung Cancer

Combining glecirasib and sitneprotafib shows encouraging efficacy and safety in patients with KRAS G12C-mutated NSCLC.